English health authority says 38 cases of new COVID variant found
Reuters
Published Feb 16, 2021 15:21
LONDON (Reuters) - Health authorities in England have identified 38 cases of a new coronavirus variant which has a key mutation that is thought to reduce the effectiveness of vaccines, the government said on Tuesday.
"There is currently no evidence that this set of mutations causes more severe illness or increased transmissibility," Professor Yvonne Doyle, Medical Director at Public Health England (PHE) said in a statement. PHE said the cases were dispersed across England.
The variant, known as B.1.525, has the E484K spike protein mutation, which is also present in the South African variant and is the key mutation found so far that could undermine the effectiveness of vaccines.
The B.1.525 variant has also been detected in Nigeria, Denmark and Canada, Public Health England said.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.